Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 119,010 shares at $6.98 ($831K) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Seasonal sale ($831k) by President and COO — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.98 | 40,044 | $280K | 33.6% |
| 2 | $6.98 | 40,044 | $280K | 33.6% |
| 3 | $6.99 | 19,461 | $136K | 16.4% |
| 4 | $6.99 | 19,461 | $136K | 16.4% |
| Total | $6.98 avg | 119,010 | $831K | 100% |
| Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-16 | $826K | — | Filing → |
| ADPT | SELL | 2026-04-13 | $758K | — | Filing → |